Navigation Links
The Pancreatic Cancer Action Network Celebrates 10 Years of Leadership and Service to the Pancreatic Cancer Community
Date:2/9/2009

EL SEGUNDO, Calif., Feb. 9 /PRNewswire/ -- The Pancreatic Cancer Action Network, the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure, celebrates ten years of progress and service to the pancreatic cancer community.

Since its inception in February 1999, the organization has grown from a small patient advocacy organization with one employee to a nationally recognized leader in the fight against the fourth leading cause of cancer death in the United States with more than 50 employees and two offices: a headquarters in El Segundo, Calif., and a Government Affairs office in Washington, D.C.

"The Pancreatic Cancer Action Network grew out of frustration about the lack of useful resources available ten years ago for those facing pancreatic cancer and their families," stated Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network. "Since that time, the organization has made tremendous progress in advancing research, supporting patients and creating hope. We are proud of the extent of services we now provide for patients and their families. We look forward to continued advancements towards a cure for this devastating disease."

Highlights over the past decade include:

  • To date, nearly $5 million in research grants will have been awarded to 50 scientists around the country. Our Career Development Awards have helped to build a team of scientists dedicated to pancreatic cancer research and our Pilot Grants are helping to develop new and innovative ideas in research.
  • Through the years, our advocacy efforts have resulted in an increase of more than $55 million in federal research dollars for pancreatic cancer. This funding is available to researchers around the country. In addition, these efforts have resulted in the first substantive piece of legislation introduced in Congress regarding pancreatic cancer research: the Pancreatic Cancer Research & Education Act. This legislation could lead to a program dedicated to pancreatic cancer at the National Cancer Institute and increased federal research funding to fight the disease.
  • More than 35,000 patients and their family members have received current and reliable information through our Patient & Liaison Services (PALS). Our comprehensive clinical trials database ensures that patients have access to the latest treatment options and leading-edge research.
  • Hundreds of supporters who are a part of 75 volunteer affiliates across the nation now raise awareness and funding for pancreatic cancer through our Community Outreach Program. Our volunteer network, which began with just a few individuals, is instrumental in encouraging people to take action again pancreatic cancer.

During the past few years, pancreatic cancer has been thrust into the national spotlight due to the diagnoses of newsmakers such as Carnegie Mellon University Professor Randy Pausch, PhD, actor Patrick Swayze, and most recently, Supreme Court Justice Ruth Bader Ginsburg. These highly publicized cases help advocates in Washington, DC, to further the organization's legislative goals and aid volunteers in heightening awareness of the disease. The increased visibility leads to increased research dollars and eventually better treatment options and renewed hope for patients.

This year, the organization will enlist its grassroots network of volunteer advocates to help ensure the federal government passes The Pancreatic Cancer Research and Education Act (H.R. 745). This bill is the first substantive legislative effort dedicated to advancing pancreatic cancer research and addresses the astounding mortality of this disease and the challenges facing the scientific community in understanding it. Once enacted and fully funded, the bill will create a greater focus on this disease and will provide the National Cancer Institute with the tools it needs to develop the diagnostic methods and treatments that are currently lacking for pancreatic cancer patients.

Reflecting on research progress, Fleshman adds, "Although much work remains, incredible strides have been made in laying the basic scientific foundation upon which significant progress can be built. As this momentum builds, and new research developments emerge, those affected by pancreatic cancer have more reasons than ever before to feel optimistic."

To learn more about the Pancreatic Cancer Action Network or to become involved, please visit www.pancan.org.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research - and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.

The Pancreatic Cancer Action Network fills the void of information and options by giving patients and caregivers reliable, personalized information they need to make informed decisions. We create a sense of hope and community so no one has to face pancreatic cancer alone. The organization helps support individuals and communities all across the country to work together to raise awareness and funds to find a cure for pancreatic cancer.


'/>"/>
SOURCE Pancreatic Cancer Action Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer
2. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
3. Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein
4. The Pancreatic Cancer Research and Education Act Addresses the Astounding Mortality of the Fourth Leading Cause of Cancer Death in the United States
5. Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes
6. Pancreatic Cancer May Have a New Foe
7. Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer
8. IDO2 an active enzyme to target in pancreatic cancer
9. Radiation before surgery improves pancreatic cancer outcomes
10. Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month
11. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... DC (PRWEB) , ... May 26, 2016 , ... There ... National Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight ... dogs, 63 percent say grilling is their favorite way to cook a hot dog, ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... discovery of thousands of defective respirators, according to court documents and SEC filings. ... of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... ... On Memorial Day, Hope For Heroes and USA Medical Card will ... country. The nonprofit Hope For Heroes partnered with the leading provider of free ... military veterans, as well as police, firemen, and EMS professionals across the country, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: